Team
Bringing together biology, machine learning, and drug development experts.
Our Team
Biology, machine learning, and drug development experts
Bio
ML
Development
Business/Ops
Founder and CEOBen Kamens
Founding engineer and VP Engineering at Khan Academy. Early engineer and VP Engineering at Fog Creek Software.
Chief Business OfficerTim Sullivan, PhD
Vice-President of Business Development at Arcus Biosciences. Senior Director of External R&D Innovation at Pfizer. Director at Takeda and ChemoCentryx.
Machine Learning LeadBen Komalo
Senior engineer and technical lead at Khan Academy. Senior engineer at Google. Member of rescue team that helped fix healthcare.gov.
VP, R&DChristian Elabd, PhD
Director of Cell Biology at BioRestorative Therapies. Postdoctoral research on aging at Berkeley. PhD in cell biology and biochemistry from University of Nice Sophia Antipolis.
Senior ScientistDaniel Chen, PhD
Postdoc researcher at Stanford investigating epigenetic memory and aging. Graduate work at UCSD investigating DNA methylation aging clock genes.
Head of ProductBrandon White
Senior Product Manager, machine learning leader, and employee #3 at Freenome. Senior ML Engineer at Uber.
Staff Software EngineerColin Fuller, PhD
Data and Infrastructure Engineer at Khan Academy. PhD work at Stanford focused on quantitative imaging and computational analysis of an in vitro system for centromere assembly.
Senior Director, R&DRachel Jacobson, PhD
Senior Principal Scientist at Kodiak Sciences, led and managed multiple pipeline projects for retinal diseases. Senior Scientist at Pfizer-Rinat Laboratories. PhD Graduate Researcher at UC Davis focused on mitochondrial dynamics.
Associate ScientistTempest Plott
Research Associate at Freenome and Crescendo Bioscience. Graduate work at UC Davis focused on shotgun proteomics and exome sequencing.
VP, Strategy & OpsAn Nguyen, PhD, MMed
Founder of Innovatively, a tech-enabled strategy partner for life science co.'s. Head of Product at Capital One. PhD from Columbia and MMed from Stanford focusing on orthopedics & tissue biomechanics.
Lead Process EngineerWilliam Van Trump, PhD
Manager of Process Engineering at Myriad Women’s Health, Director of Process Engineering at EpiBiome, Senior Manager of Engineering at Illumina. PhD from UC Irvine with a focus on Sensory Biomechanics.
Senior Data ScientistMichael Wiest
Data scientist at Trace Genomics. Graduate work at UCSD focusing on deep learning approaches for characterizing the human gut microbiome. Terrible surfer.
Senior Manager, Strategy & OpsKelly Reynolds
Deputy Director, Administrative Operations & Planning at The Annenberg Foundation Trust at Sunnylands. Assistant General Manager at The TwinEagles Club.
Lab ManagerElisa Cambronero
Research Associate at Bio-Rad Laboratories. B.S. in Biochemistry from California State University, Northridge.
Staff Machine Learning ScientistFrancesco Rubbo, PhD
Research Manager and Scientist at Clarifai. Software Engineer at Apple. Particle Physics Researcher at Stanford. PhD in Physics from Universitat Autonoma de Barcelona.
Senior Machine Learning ScientistZach Barry, PhD
Data Scientist at Novartis Institutes for BioMedical Research (NIBR) focused on deep learning-based analysis of preclinical microscopy/imaging data. PhD in Biological Engineering from MIT.
Machine Learning ScientistAhmed Hosny, PhD
Machine Learning Scientist at Dana-Farber Cancer Institute and Wyss Institute. Computational Imaging PhD at Maastricht University. Architect in a former life. Aspiring pilot.
Associate Director, Program Management & StrategyRuchi Masand, PhD
Sr. Manager of R&D Ops & NPP at Epirium Bio. Postdoc in obesity research at UCSF-CVRI. PhD focused on mitochondrial disease genetics at Baylor College of Medicine.
Staff Machine Learning ScientistAaditya (Adi) Prakash, PhD
Manager of Machine Learning Research at Path AI. Research Scientist at Philips. Ph.D. from Brandeis in Deep Learning. Hiker, climber, and wanderer.
Advisors
World leaders in biology, drug development, and tech
AdvisorSasha Kamb, PhD
Senior Vice President of Research, Head of Neuroscience Discovery at Amgen. President/CSO A2 Biotherapeutics.
AdvisorBob Abraham, PhD
Senior Vice President and Group Leader at Pfizer. Chief Scientific Officer at Vividion Therapeutics. Co-discoverer of mTOR.
AdvisorHoward Chang, PhD
Head of Chang Lab, Professor of Dermatology, and Virginia and D.K. Ludwig Professor of Cancer Genomics and Genetics at Stanford. Scientific cofounder of Epinomics.
AdvisorSaul Villeda, PhD
Head of Villeda Lab for aging research at UCSF. PhD from Stanford with focus on reversing aging in the brain.
AdvisorSam Altman
CEO of OpenAI. Former president of Y Combinator.
AdvisorSteve Young, PhD
Vice President, Arcus Bio. Previously Executive Director and head of first automated screening lab at Amgen.
AdvisorThomas Hughes, PhD
CEO of Navitor Pharma. Previous CSO and CEO at Zafgen, as well as Global Head of Cardiovascular and Metabolic Diseases at Novartis.
AdvisorDaniel Delubac, PhD
VP Lab Tech and Operations at Freenome. Previous Head of Process Engineering and Automation at Guardant and Engineering Lead at Counsyl.
Board
ChairmanElad Gil
Cofounder of Color Genomics. Previously VP Corporate Strategy at Twitter and early PM at Google. Investor or advisor to AirBnB, Square, Stripe, Pinterest, Gusto, and more. PhD Biology from MIT.
Board memberHemant Taneja
Managing Director of General Catalyst. Portfolio ranges across medicine, energy, education, media, and finance, and includes Livongo Health, Stripe, Snapchat, Gusto, and more. Five degrees from MIT.
Board memberPaul Sekhri
President and CEO of eGenesis. Previously president and CEO of Lycera, group executive vice president and chief strategy officer of Teva, and operating partner at TPG Biotech. Board member at Veeva, Pharming, and more.
Board observerJosh Kopelman
Co-founder and Managing Director of First Round Capital. Active entrepreneur and investor in the Internet industry since its commercialization. Founded Half.com (sold to Ebay) and TurnTide (sold to Symantec).
Board observerKatherine Boyle
Partner at General Catalyst. Investor in Nova Credit, Literati, Anduril, and more. Previously reporter for the Washington Post, investing entrepreneurship. MBA at Stanford.
Founder and CEOBen Kamens
Founding engineer and VP Engineering at Khan Academy. Early engineer and VP Engineering at Fog Creek Software.
Investors
Sam Altman
PartnershipsSpring's tech is used by a range of partners across biotech, pharma, and academic research. We provide both strategic collaborations and software licensing to those looking for novel biological insights or tools to accelerate their science. Contact us.
© 2023 Spring Discovery. All rights reserved.
© 2022 Spring Discovery.All rights reserved.